Skip to main content
. 2019 May 7;27(6):350–354. doi: 10.1136/ejhpharm-2018-001806

Table 3.

Statistical analysis of survivors versus non-survivors FVC at baseline and throughout time

n Mean±SD (%) Statistical significance
FVC (%) baseline Survivors 24 64.92±9.63 p=0.770
Non-survivors 7 51.43±14.63
FVC (%) first year Survivors 15 70.60±18.43 p=0.033
Non-survivors 5 46.80±15.29
FVC (%) second year Survivors 9 68.78±15.05 p=0.491
Non-survivors 2 54.50±4.95
FVC (%) third year Survivors 4 78.75±20.25 p=1.00
Non-survivors 1 40.00±0.00

Significance p<0.05 (95% CI). A non-survivor was a patient who died at any time.

FVC, forced vital capacity.